[HTML][HTML] A complement C4–derived glycopeptide is a biomarker for PMM2-CDG

K Garapati, R Budhraja, M Saraswat, J Kim, N Joshi… - JCI insight, 2024 - ncbi.nlm.nih.gov
BACKGROUND Diagnosis of PMM2-CDG, the most common congenital disorder of
glycosylation (CDG), relies on measuring carbohydrate-deficient transferrin (CDT) and …